153804-48-9 Usage
Molecular structure
A complex structure comprising a thiochroman ring, a butyl chain, and an isoindole-1,3-dione core.
Heterocyclic compound
Consists of both carbon and other non-carbon atoms (such as sulfur) in its ring structure.
Aromatic ring
The thiochroman ring contains delocalized electrons, giving it aromatic properties.
Sulfur-containing
The thiochroman ring includes a sulfur atom, which may contribute to the compound's reactivity and potential applications.
Alkyl group
The butyl chain is a four-carbon (C4) alkyl group attached to the thiochroman ring.
Cyclic imide
The isoindole-1,3-dione core is a cyclic imide with two carbonyl groups (C=O).
Potential pharmaceutical applications
The compound may have potential uses in the pharmaceutical industry, but further research and investigation are needed to determine specific applications.
Reactivity
The presence of sulfur and carbonyl groups may contribute to the compound's reactivity with other chemical species.
Physical and chemical properties
The specific properties, such as solubility, boiling point, and melting point, would require experimental determination.
Further research needed
The compound's specific properties, uses, and potential applications are not fully known and require additional investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 153804-48-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,8,0 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 153804-48:
(8*1)+(7*5)+(6*3)+(5*8)+(4*0)+(3*4)+(2*4)+(1*8)=129
129 % 10 = 9
So 153804-48-9 is a valid CAS Registry Number.
InChI:InChI=1/C21H21NO3S/c23-20-16-9-1-2-10-17(16)21(24)22(20)12-3-4-13-25-18-11-5-7-15-8-6-14-26-19(15)18/h1-2,5,7,9-11H,3-4,6,8,12-14H2
153804-48-9Relevant academic research and scientific papers
THIOCHROMAN COMPOUNDS
-
, (2008/06/13)
The invention relates to compounds of the formula I: STR1 in which R 1 is as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base, andmedicinal products which are useful for treating Central Nervous System disorders.
